Photo from wikipedia
e20046Background: Increase availability of oral anticancer drugs has raised concerns about patient adherence. In 2017, lenalidomide was approved as maintenance therapy for multiple myeloma (MM) aft... Click to show full abstract
e20046Background: Increase availability of oral anticancer drugs has raised concerns about patient adherence. In 2017, lenalidomide was approved as maintenance therapy for multiple myeloma (MM) aft...
Keywords:
maintenance;
lenalidomide;
multiple myeloma;
self reported;
adherence
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!